Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative iron deficiency anaemia trial
ACTRN12614001261606Phase 4Completed
- Sponsor
- University of Tasmania
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric carboxymaltose in iron deficiency anemia (IDA) (3 arms), sponsored by University of Tasmania. Primary endpoints: Efficacy of IV iron in postoperative anaemia, Blood transfusion requirement and 1 more. Started Dec 2014; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12614001261606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001261606.